Neuro-Oncology Reviews

Volume 26 Number 27
30 November 2024

Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 27, 30 November

Badani A, Ozair A, Khasraw M, Woodworth GF, Tiwari P, Ahluwalia MS, Mansouri A.
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions.
J Neurooncol. 2024 Nov 21. doi: 10.1007/s11060-024-04881-2. PMID: 39570554. Review˰ ˍ

Broggi G, Salzano S, Failla M, Barbagallo GMV, Certo F, Zanelli M, Palicelli A, Zizzo M, Koufopoulos N, Magro G, Caltabiano R.
Clinico-Pathological Features of Diffuse Midline Glioma, H3 K27-Altered in Adults: A Comprehensive Review of the Literature with an Additional Single-Institution Case Series.
Diagnostics (Basel). 2024 Nov 21;14(23):2617. doi: 10.3390/diagnostics14232617. PMID: 39682526. Case report; Review. ˍ

Franco MS, Raulefs S, Schilling D, Combs SE, Schmid TE.
Impact of Radiation on Invasion and Migration of Glioma In Vitro and In Vivo.
Cancers (Basel). 2024 Nov 21;16(23):3900. doi: 10.3390/cancers16233900. PMID: 39682088. Review. ˍ

Hansford JR, Manoharan N, Bouche G, Ramaswamy V, Jabado N, Bouffet E.
ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?
Expert Opin Emerg Drugs. 2024 Nov 21:1-5. doi: 10.1080/14728214.2024.2426649. PMID: 39548664. Perspective. ˍ

Percuoco V, Herlin E, Prada F, Riva M, Pessina F, Staartjes VE, Della Pepa GM, Menna G.
Glioblastoma invasion patterns from a clinical perspective-a systematic review.
Neurosurg Rev. 2024 Nov 21;47(1):864. doi: 10.1007/s10143-024-02944-6. PMID: 39570467. Review. ˍ

Rossi J, Zedde M, Napoli M, Pascarella R, Pisanello A, Biagini G, Valzania F.
Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.
Life (Basel). 2024 Nov 21;14(12):1523. doi: 10.3390/life14121523. PMID: 39768232. Review. ˍ

Zeng L, Yang H, Li H, Chen R, Chen J, Yu J.
Risk factors for and molecular pathology characteristics of systemic metastasis of adult cerebral glioblastoma: A pooled individual patient data analysis and systematic review.
J Neurol Surg A Cent Eur Neurosurg. 2024 Nov 21. doi: 10.1055/a-2479-9978. PMID: 39572244. Review˰ ˍ

Balasubramanian K, Zuccato JA, Kharbat AF, Janssen C, Gonzalez NM, Dunn IF.
Primary Extradural Meningioma: A Systematic Review of Diagnostic Features, Clinical Management, and Surgical Outcomes.
Cancers (Basel). 2024 Nov 22;16(23):3915. doi: 10.3390/cancers16233915. PMID: 39682104. Review. ˍ

Cómitre-Mariano B, Vellila-Alonso G, Segura-Collar B, Mondéjar-Ruescas L, Sepulveda JM, Gargini R.
Sentinels of neuroinflammation: the crucial role of myeloid cells in the pathogenesis of gliomas and neurodegenerative diseases.
J Neuroinflammation. 2024 Nov 22;21(1):304. doi: 10.1186/s12974-024-03298-y. PMID: 39578808. Review. ˍ

Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson MD, Kalamarides M, Lamszus K, Albert NL, Mair MJ, Berghoff AS, Mawrin C, Wirsching HG, Maas SL, Raleigh DR, Reifenberger G, Schweizer L, Suwala AK, Tabatabai G, Tabouret E, Short S, Wen PY, Weller M, Le Rhun E, Wesseling P, van den Bent M, Preusser M.
EANO guideline on molecular testing of meningiomas for targeted therapy selection.
Neuro Oncol. 2024 Nov 22:noae253. doi: 10.1093/neuonc/noae253. PMID: 39577862. Guidelines. ˍ

Shah S, Nag A, Sachithanandam SV, Lucke-Wold B.
Predictive and Prognostic Significance of Molecular Biomarkers in Glioblastoma.
Biomedicines. 2024 Nov 22;12(12):2664. doi: 10.3390/biomedicines12122664. PMID: 39767571. Review. ˍ

Babič D, Jovčevska I, Zottel A.
B7-H3 in glioblastoma and beyond: significance and therapeutic strategies.
Front Immunol. 2024 Nov 25;15:1495283. doi: 10.3389/fimmu.2024.1495283. PMID: 39664380. Review. ˍ

Ismail FS, Gallus M, Meuth SG, Okada H, Hartung HP, Melzer N.
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology: A Review.
JAMA Neurol. 2024 Nov 25. doi: 10.1001/jamaneurol.2024.3818. PMID: 39585688. Review˰ ˍ

Patel MP, Serventi JN, Dunbar EM, Oliver K, Piil K, Seute T, Chang S.
Vorasidenib: Patient and caregiver information sheet.
Neurooncol Pract. 2024 Nov 25;12(Suppl 1):i26-i28. doi: 10.1093/nop/npae081. PMID: 39776531. Review. ˍ

Prakash V, Gabrani R.
Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine.
Neurogenetics. 2024 Nov 25;26(1):5. doi: 10.1007/s10048-024-00793-5. PMID: 39585441. Review˰ ˍ

Salomoni P.
Understanding brain cancer and exploiting its vulnerabilities.
Mol Oncol. 2024 Nov 25. doi: 10.1002/1878-0261.13769. PMID: 39582358. Editorial. ˍ

Soukup J, Hajkova N, Hajkova V, Svajdler M, Netuka D, Majovsky M.
A glioneuronal tumor with neurocytic rosettes harboring FGFR1 internal tandem duplication - A report of a unique case.
Neuropathology. 2024 Nov 25. doi: 10.1111/neup.13018. PMID: 39586795. Case report; Review˰ ˍ

Sharma S, Gone GB, Roychowdhury P, Kim HS, Chung SJ, Kuppusamy G, De A.
Photodynamic and sonodynamic therapy synergy: mechanistic insights and cellular responses against glioblastoma multiforme.
J Drug Target. 2024 Nov 26:1-15. doi: 10.1080/1061186X.2024.2431676. PMID: 39556529. Review˰ ˍ

Bou-Gharios J, Noël G, Burckel H.
The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies.
BMC Biol. 2024 Nov 28;22(1):278. doi: 10.1186/s12915-024-02075-w. PMID: 39609830. Review. ˍ

Liu X, Chen H, Tan G, Zhong L, Jiang H, Smith SM, Wang HZ.
A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence.
Front Immunol. 2024 Nov 28;15:1496627. doi: 10.3389/fimmu.2024.1496627. PMID: 39669560. Review. ˍ

Hajikarimloo B, Habibi MA, Kooshki A, Alvani MS, Zare AH, Hasanzade A, Zare AH, Akhlaghpasand M, Tavanaei R, Tos SM.
Dabrafenib plus trametinib in low-grade versus high-grade gliomas: a systematic review and meta-analysis.
BMC Cancer. 2024 Nov 29;24(1):1473. doi: 10.1186/s12885-024-13229-y. PMID: 39614165. Review; Meta-analysis. ˍ

Li W, Wang Z, Chen S, Zuo M, Xiang Y, Yuan Y, He Y, Zhang S, Liu Y.
Metabolic checkpoints in glioblastomas: targets for new therapies and non-invasive detection.
Front Oncol. 2024 Nov 29;14:1462424. doi: 10.3389/fonc.2024.1462424. PMID: 39678512. Review. ˍ

Swensen SN, Figuracion KCF, Venur VA, Emerson S, Tseng YD, Lo SS, Ermoian RP, Halasz LM.
Treatment Options for IDH-Mutant Malignant Gliomas.
Curr Treat Options Oncol. 2024 Nov 29. doi: 10.1007/s11864-024-01280-7. PMID: 39612163. Review˰ ˍ

Wu H, Cheng K, Sun Z, Lu Y, Guo Q, Li C.
Trends of mapping knowledge structure and themes of cancer sonodynamic therapy: a text-mining study.
Quant Imaging Med Surg. 2024 Nov 29;14(12):8734-8757. doi: 10.21037/qims-24-128. PMID: 39698701. Bibliometric analysis. ˍ

Krzemińska A, Czapiga B, Koźba-Gosztyła M.
Accuracy of Raman spectroscopy in discriminating normal brain tissue from brain tumor: A systematic review and meta-analysis.
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Nov 30;329:125518. doi: 10.1016/j.saa.2024.125518. PMID: 39637568. Review; Meta-analysis. ˍ